Lymphoma immunotherapy to train the body to fight bad B-cells like viruses …MedCity NewsCurrently approved biologics for lymphoma include Rituximab (Genentech), Ibritumomab tuixetan (Spectrum Pharmaceuticals) and Tositumomab (GSK), which are part of …
VIDEO: Dr. De Meirleir on Oxygen Therapy, Rituximab, Ampligen, Pacing, Fecal …ProHealthAdministration of oxygen therapy has advantages and disadvantages. Oxygen increases the release of free radicals, which can be harmful. On the other hand oxygen ca…
|
SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for …
PipelineReview.com (press release) Tell your doctor about all the medications you take including ORENCIA (abatacept), KINERET (anakinra), ACTEMRA (tocilizumab), RITUXAN (rituximab), or another TNF blocker, or if you are scheduled to or recently received a vaccine. People receiving … |
Insider Monkey (blog) |
What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Insider Monkey (blog) Biogen Idec Inc (NASDAQ:BIIB) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs … |
|
SIMPONI® ARIA™ (golimumab) For Infusion Receives FDA Approval For …
The Herald | HeraldOnline.com Tell your doctor about all the medications you take including ORENCIA (abatacept), KINERET (anakinra), ACTEMRA (tocilizumab), RITUXAN (rituximab), or another TNF blocker, or if you are scheduled to or recently received a vaccine. People receiving … |
|
What Does Celgene’s Failed Trial Mean for Investors?
DailyFinance Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs in the world (it is also approved for non-Hodgkin’s lymphoma and rheumatoid arthritis). It is about to get much cheaper for patients, too. A total of 12 … |
Halozyme: Drug Delivery Specialist With Multiple CatalystsSeeking AlphaHerceptin-SC (trastuzumab) and MabThera-SC (rituximab) (novel subcutenous injected rHuPH20 formulations) are currently pending European Medicines Agency (EMA) decisions in the form …
|
What Does Celgene’s Failed Trial Mean for Investors?
Motley Fool Biogen Idec (NASDAQ: BIIB ) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs in … |
In brief: research round-upMedical Physics Web (subscription)Radio-immunotherapy with the low-energy beta emitter 177Lu-DOTA-rituximab is safe and effective for lymphoma patients, according to a study from Kantonsspital Baselland and University Hospita…
|
Steroid-free treatment of lupus nephritis a reality
Rheumatology Update In a “game changing” study, UK clinicians have shown that lupus nephritis can be successfully treated without oral steroids by using the immunosuppreant rituximab. The breakthrough may allow patients with lupus to avoid the significant morbidity and … |